Corcept Therapeutics CORT FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's FX effect on cash?
- Corcept Therapeutics (CORT) reported FX effect on cash of -$287K in Q1 2026.
- How has Corcept Therapeutics's FX effect on cash changed year-over-year?
- Corcept Therapeutics's FX effect on cash decreased by 180.2% year-over-year, from $358K to -$287K.
- What does FX effect on cash mean?
- The change in cash value caused by shifting foreign currency exchange rates.
- How do you interpret FX effect on cash?
- Larger values indicate higher exposure to foreign currency volatility, which may impact reported cash positions.
- How does FX effect on cash compare across companies?
- Standard adjustment for multinational corporations; peers report this as a reconciliation item in the cash flow statement.